Can anticoagulants improve outcomes in patients with pulmonary arteriovenous malformations, and what role do they play in reducing complications?
Gaurav ChauhanContributor
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
No, anticoagulants are not typically used to improve outcomes in patients with pulmonary arteriovenous malformations, as their primary role is not to reduce or eliminate the malformations but to manage blood clot risks.